Methylphenidate approved indications include ADHD and narcolepsy; which is NOT an approved indication?

Methylphenidate approved indications include ADHD and narcolepsy; which is NOT an approved indication?

• A. ADHD
• B. Narcolepsy
• C. Reversal of respiratory distress
• D. Depression

Answer: (D)

Methylphenidate is a CNS stimulant whose approved uses are ADHD and narcolepsy. Its mechanism—boosting dopamine and norepinephrine in the brain—underpins its ability to improve attention and wakefulness, which fits those two conditions. Depression, on the other hand, is not a labeled indication for methylphenidate; treating mood disorders relies on antidepressants and other therapies, not this stimulant. So the statement describes an option that isn’t an approved use. Reversal of respiratory distress isn’t a recognized indication either, but the labeling and common exam focus center on depression as the nonapproved indication here.

Methylphenidate is a CNS stimulant whose approved uses are ADHD and narcolepsy. Its mechanism—boosting dopamine and norepinephrine in the brain—underpins its ability to improve attention and wakefulness, which fits those two conditions. Depression, on the other hand, is not a labeled indication for methylphenidate; treating mood disorders relies on antidepressants and other therapies, not this stimulant. So the statement describes an option that isn’t an approved use. Reversal of respiratory distress isn’t a recognized indication either, but the labeling and common exam focus center on depression as the nonapproved indication here.